Dr. Axel Heidenreich - Comparing Treatment in the US & Europe
Dr. Axel Heidenreich - Comparing Treatment in the US & Europe
Episode 125
In this episode of It Takes Balls, internationally renowned urologic oncologist Dr. Axel Heidenreich joins the podcast for a fascinating conversation comparing testicular cancer treatment in Europe (focused on Germany) and the United States. Although both approaches produce exceptional cure rates, patients are often surprised to learn just how differently experts on opposite sides of the Atlantic make treatment decisions.
Dr. Heidenreich explains where the European Association of Urology (EAU), American Urological Association (AUA), and National Comprehensive Cancer Network (NCCN) guidelines align and where they take very different paths. From surveillance and chemotherapy to RPLND, imaging, and follow-up care, he shares why there isn't always one "right" answer and how physicians balance curing cancer with preserving quality of life.
The conversation also dives into one of the most debated topics in testicular cancer today: the future of surveillance. Dr. Heidenreich discusses emerging blood tests that could reshape how recurrence is detected and monitored, offering his perspective. Rather than accepting the latest technology at face value, he explains why some innovations may hold more promise than others and what that could mean for the future of testicular cancer care.
Whether you're newly diagnosed, currently on surveillance, or simply interested in how leading experts think differently around the world, this episode offers an eye-opening look at the evolution of testicular cancer treatment and the questions that could shape the next generation of patient care.
Provide your feedback on the podcast here.
Click the links below to listen: